Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Tartu University Hospital
Sponsor

Tartu University Hospital

Estonia L. Puusepa Tn 1a, 50406 Tartu, Estonia

About the sponsor

Tartu University Hospital is involved in clinical research on advanced prostate cancer and glioblastoma multiforme, with studies focused on treatment-resistant disease, tumour control, and survival outcomes.

  • Castration-resistant prostate cancer
  • Taxane-resistant disease
  • Glioblastoma multiforme

The oncology portfolio includes interest in combined systemic therapy, precision radiotherapy, and treatment strategies used alongside standard neuro-oncology care.

About Specializations

Tartu University Hospital runs clinical trials in conditions such as Prostate cancer, Osteoarthritis, Glioblastoma multiforme, Critical illness, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

5 clinical trials

Prostate cancer

Not yet recruiting

Study of vinorelbine and cisplatin with radiation therapy for patients with castration- and taxane-resistant prostate cancer

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Tartu University Hospital

Osteoarthritis

Not yet recruiting

Study on the Use of Autologous Adipose Tissue-Derived Stromal Vascular Fraction for Patients with Advanced Temporomandibular Joint Osteoarthritis

InvestigationalNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years
  • Substances:Autologous Adipose Tissue-Derived Stromal Vascular Fraction
  • Sponsor:Tartu University Hospital

Glioblastoma multiforme

Not recruiting

Study on LSTA1 and Temozolomide for Patients with Newly Diagnosed Glioblastoma Multiforme

Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:LSTA1
  • Sponsor:Tartu University Hospital

Critical illness

Not recruiting

Study on Vancomycin Hydrochloride for Treating Serious Infections in Critically Ill Adults Using a Precision Dosing Tool

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Vancomycin Hydrochloride
  • Sponsor:Tartu University Hospital

Chronic rhinosinusitis with nasal polyps

Not recruiting

Study on Secukinumab for Treating Chronic Rhinosinusitis with Nasal Polyps in Non-Type 2 Patients

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years
  • Substances:Secukinumab
  • Sponsor:Tartu University Hospital

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.